Recent Updates
Recently added Catalysts
LXRX

Lexicon Advances LX4211 In Type 1 Diabetes Phase 2 Trial

Friday, May 10, 2013 1 min read
Key Takeaway: Lexicon Advances LX4211 In Type 1 Diabetes Phase 2 Trial

Full Press Release Details

Lexicon Advances LX4211 In Type 1 Diabetes Phase 2 Trial.
Tags: LXRX Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: May 10, 2013